Data / Form D filings / ProPhase Labs, Inc.
ProPhase Labs, Inc.: Form D filings
ProPhase Labs, Inc., a biotechnology company in Uniondale, NY, filed 4 Form D notices with the SEC between 2010 and 2025. The latest, on August 5, 2025, reports $3 million sold of a $6 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 626 RXR PLAZA, 6TH FLOOR, Uniondale, NY, 11556
- Phone
- (215) 345-0919
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 868278
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | New notice | $6,000,000 | $3,000,000 | $3,000,000 | 2 | Jul 22, 2025 | sec.gov |
| Jul 7, 2025 | New notice | $1,000,000 | $1,000,000 | 2 | Jun 22, 2025 | sec.gov | |
| Dec 28, 2015 | New notice | $3,000,000 | $1,500,000 | $1,500,000 | 2 | Dec 11, 2015 | sec.gov |
| Mar 26, 2010 | New notice | $2,923,200 | $2,923,200 | 1 | Mar 22, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| LOUIS GECKEL | Director | |
| WARREN HIRSCH | Director | |
| CAROLINA ABENANTE | Director | |
| TED KARKUS | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ProPhase Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.